- Press Release -

Rockville, Md. The global vaccine delivery devices market is set to grow at a 9.5% CAGR from 2022 to 2032 and surpass US$ 10 Bn by the end of that period, according to Fact.MR, after topping US$ 4 Bn by 2022-end. Widening immunization programs and vaccination drives are the main engine, and initiatives such as the GAVI Alliance and the Bill & Melinda Gates Foundation have given the market a meaningful lift.

Syringes lead the product mix, intramuscular delivery is the largest route, North America is a key revenue hub, and Asia Pacific excluding Japan is the fastest-growing region. The COVID-19 pandemic sharpened the need for efficient delivery devices, accelerating growth from the 8% CAGR seen between 2017 and 2021.

Products, Routes and Regions

Syringes are the most lucrative product, accumulating US$ 900 Mn in value, while intramuscular delivery devices reach US$ 1 Bn by 2022. North America grows at a 10% CAGR as a key revenue hub, and Asia Pacific excluding Japan is the most opportunistic market at a 12% CAGR from 2022 to 2032. Wider use across influenza, hepatitis A and B, and meningitis reinforces demand.

Immunization Drives Demand

The market runs on public health. As governments and non-government organisations expand vaccination efforts, and as pandemic preparedness stays high on the agenda, demand for reliable delivery devices keeps climbing through the forecast period.

Competitive Landscape

Key players pursue acquisitions, partnerships and collaborations to strengthen their positions. Recent moves include the Serum Institute of India taking a 50% stake in packaging firm Schott Kaisha in August 2021, Zealand Pharma's acquisition of Valeritas Holdings in April 2020, and Gerresheimer's November 2021 partnership with Midas Pharma on a new-generation auto injector.

Reading the Market for Decisions

For device makers, growth favours syringes and intramuscular delivery aligned to immunization programs. Investors get a fast-growing market with a firm public-health tailwind. Procurement and health-system teams can plan around syringes carrying volume, North America as a revenue hub, and Asia Pacific offering the fastest growth through 2032.

About the Report

Fact.MR's study covers the global vaccine delivery devices market with historical data for 2017 to 2021 and forecasts for 2022 to 2032, segmented by product and route of administration across six regions. It sizes each segment, maps the competitive field, and weighs the public-health forces shaping demand. Further detail is available in the vaccine delivery devices market report.

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. The firm is known for its syndicated research, custom research and consulting solutions, helping clients make decisions on demand, competition, investment, procurement and future growth.